PP09 Presentation Time: 11:20 AM

This study aimed to evaluate outcomes associated with a single-fraction high-dose-rate (HDR) brachytherapy boost combined with five-fraction stereotactic body radiation therapy (SBRT) for patients with unfavorable intermediate- or high-risk prostate cancer.

Source: Brachytherapy - May 1, 2021 Category: Cancer & Oncology Authors: Daniel Gorovets, Margaret Hopkins, Assaf Moore, Arrun Goel, Marisa Kollmeier, Daniel Shasha, Victoria Brennan, Sean McBride, Gilad Cohen, Antonio Damato, Michael J. Zelefsky Source Type: research